Sales of Injectable Benzodiazepine Market are predicted to reach $274 million by the end of 2022. Sales of injectable benzodiazepines are predicted to reach US$ 356 million by 2032’s end. From 2022 to 2032, the injectable benzodiazepines market is anticipated to expand at a 2.7% CAGR. Global Injectable Benzodiazepine Market sales are set to reach …
Category Archives: Healthcare Trends
Swab and Viral Transport Medium Market | Cardinal Health Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Quidel Corporation | By
According to a recent market analysis by FMI, the global Swab and Viral Transport Medium Market might reach over US$ 8.86 billion in 2023. The market might grow at a 5.8% CAGR and reach a value of US$ 15.60 billion by 2033, according to FMI’s forecast. Swabs and viral transport mediums are in higher demand …
Respiratory Pathogen Testing Kits Market is projected to surpass US$ 7,136.8 million record a CAGR of 5.7% through 2033
As per the latest market research conducted by FMI, the global Respiratory Pathogen Testing Kits Market is expected to record a CAGR of 5.7% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 4083.1 million. By 2033, the valuation is anticipated to reach US$ 7136.8 million. The …
Non-opioid Pain Patches Market is Expanding at a healthy 4.1% CAGR, the size is projected to total US$ 4.4 Billion by 2029
In 2022, sales of Non-opioid Pain Patches Market are anticipated to reach US$ 3.3 billion. By 2029, the market size is expected to reach US$ 4.4 Billion, growing at a robust 4.1% CAGR. In recent years, non-opioid pain patches have gained huge attention of leading industry players due to the addictive risk and safety concerns …
Preterm Birth Prevention and Management Market | Biophar Lifesciences Pvt. Ltd., Jasco Labs (P) Ltd., BSA Pharma Inc., Pfizer Inc | By 2029
The global Preterm Birth Prevention and Management Market is estimated to be worth around US$ 1.41 Billion in 2022. With increasing adoption of preterm birth prevention and management therapeutics across both developed and developing regions, the overall market is anticipated to grow at 10.1% CAGR between 2022 and 2029, totaling a valuation of US$ 2 .78 …
Fiducial Markers Market to reach a valuation of ~US$ 408.3 Million by the year 2033 | Says Future Market Insights
The global fiducial markers market is worth US$ 153.6 Million as of now and is expected to reach US$ 408.3 Million by the year 2033 at a CAGR of 10.3% between 2023 and 2033. With growing awareness regarding targeted radiotherapy techniques like image-guided radiotherapy, stereotactic radiosurgery, and intensity-modulated radiotherapy, fiducial markers are expected to witness an explicit …
Laryngoscopes Market is anticipated to cross a value of US$ 601.6 million by 2033 | Get Insights FMI
The demand for laryngoscopes is rising in response to the increasing incidence prevalence of laryngeal diseases such as laryngitis, larynx cancer, and diseases affecting vocal nodules. According to a new study by Future Market Insights (FMI), the laryngoscopes market is likely to rise at above 5% CAGR between 2020 and 2030. Laryngoscopes help in the insertion of …
Microneedle Drug Delivery Systems Market size is projected to reach a valuation of US$ 768.9 million by 2033
[238 Pages Report] Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2020 and 2030. The market is witnessing surging demand in the field …
Therapeutic Respiratory Devices Market is assessed to reach US$ 80.2 billion by 2033, registering a CAGR of 4.7% between 2023 to 2032 | FMI Study
In 2023, it is predicted that the market for therapeutic respiratory devices will be worth $50.6 billion. The market is anticipated to grow at a CAGR of 4.7% from 2023 to 2033, reaching US$ 80.2 billion by 2033. Because respiratory conditions like COPD and sleep apnea are becoming more common, the market for therapeutic respiratory devices is …
Spike in Incidences of Cancer to drive the Gamma Probe Devices Market, reaching US$ 244.3 Million by the year 2033 at a CAGR of 9.8% from 2023 to 2033
The global gamma probe devices market is worth US$ 86.9 Million as of now and is expected to reach ~US$ 244.3 Million by the year 2033 at a CAGR of 9.8% between 2023 and 2033. Gamma probe devices do facilitate identification of radio-labeled tissue at the time of intra-operation as well as pre-operation for radio guided surgery …